Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed2
Recruiting1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01127087Phase 1/2Completed
Oxazyme in Patients With Hyperoxaluria
Hyperoxaluria
Principalinvestigator
NCT02096965Phase 1Completed
Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study
Nephrolithiasis, Calcium OxalateNephrolithiasis, Calcium Phosphate
Principalinvestigator
NCT02780297Recruiting
Prospective Research Rare Kidney Stones (ProRKS)
Adenine Phosphoribosyltransferase DeficiencyCystinuriaDent Disease+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vidar Edvardsson, MD

APRT Registry, Landspitali University Hospital, Iceland

Related
1 trials

Shared therapeutic areas:

CystinuriaDent Disease

Worked with same sponsors:

Mayo Clinic
Similarity Score9%

Dawn S. Milliner, M.D.

Primary Hyperoxaluria Registry - Mayo Clinic, Rochester, MN

Related
1 trials

Shared therapeutic areas:

CystinuriaDent Disease

Worked with same sponsors:

Mayo Clinic
Similarity Score9%

John C Lieske, M.D.

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Dent DiseaseCystinuria

Worked with same sponsors:

Mayo Clinic
Similarity Score9%

John C Lieske, MD

Dent Disease Registry, Mayo Clinic, Rochester, MN

Related
1 trials

Shared therapeutic areas:

CystinuriaDent Disease

Worked with same sponsors:

Mayo Clinic
Similarity Score9%

Sonia Fargue, PhD

University of Alabama at Birmingham

Related
4 trials

Shared therapeutic areas:

Nephrolithiasis, Calcium OxalateHyperoxaluria
Similarity Score9%

Stephen B. Erickson, M.D.

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

CystinuriaNephrolithiasis, Calcium Oxalate

Worked with same sponsors:

Mayo Clinic
Similarity Score9%

David Goldfarb, MD

Cystinuria Registry, New York University, NY

Related
1 trials

Shared therapeutic areas:

CystinuriaDent Disease

Worked with same sponsors:

Mayo Clinic
Similarity Score9%

David Goldfarb, MD

NYU Langone Health

Related
7 trials

Shared therapeutic areas:

CystinuriaDent Disease
Similarity Score9%

Dawn S Milliner, M.D.

Mayo Clinic Hyperoxaluria Center, Rochester MN

Related
1 trials

Shared therapeutic areas:

Hyperoxaluria

Worked with same sponsors:

Mayo Clinic
Similarity Score4%

John D Denstedt, MD, FRCSC

The University of Western Ontario (Professor)

Related
1 trials

Shared therapeutic areas:

Hyperoxaluria
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01127087Phase 1/2PrincipalInvestigator

Oxazyme in Patients With Hyperoxaluria

Hyperoxaluria
Completed
NCT02096965Phase 1PrincipalInvestigator

Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study

Nephrolithiasis, Calcium OxalateNephrolithiasis, Calcium Phosphate
Completed
NCT02780297PrincipalInvestigator

Prospective Research Rare Kidney Stones (ProRKS)

Adenine Phosphoribosyltransferase DeficiencyCystinuriaDent Disease+2 more
Recruiting

All 3 trials loaded